Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study

Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study

Abstract Background Peritoneal carcinomatosis (PC) from colorectal cancer is associated with poor prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has improved survival for patients with colorectal peritoneal carcinomatosis. However, standardizat...

Full description

Bibliographic Details
Main Authors: Atuhani Burnett, Marie-Eve Aubé Lecompte, Nora Trabulsi, Pierre Dubé, Mai-Kim Gervais, Bertrand Trilling, Alexis-Simon Cloutier, Lucas Sideris
Format: Article
Language:English
Published: BMC 2019-05-01
Series:World Journal of Surgical Oncology
Subjects:
Colorectal cancer
HIPEC
Oxaliplatin
Peritoneal carcinomatosis
Online Access:http://link.springer.com/article/10.1186/s12957-019-1618-4

Internet

http://link.springer.com/article/10.1186/s12957-019-1618-4

Similar Items